Recent Articles

• 
  Diagnostics / Monitoring

  Retinal Diseases Hard to Treat, Manage Before Symptoms

  Getty Image Bank Professor Yoon Young-hee When vision deteriorates, many people first think of presbyopia. However, decreased vision is not simply a sign of aging; it may be a warning that retinal diseases, which can lead to blindness, are quietly progressing. Major retinal diseases such as age-rela

  2026.02.11
• 
  Medical / Drug Development

  High-Risk Recurrent Ovarian Cancer Needs Early Targeted Care

  Ovarian cancer accounts for 1.2% of all cancers occurring in Korea (as of 2022), so it is not as common as other gynecologic cancers such as breast cancer or cervical cancer. However, it is so lethal that it ranks first in mortality among gynecologic cancers. Known as the “silent killer,” ovarian ca

  2026.02.11
• 
  AI Healthcare

  AI Coronary Flow Analysis Boosts Gangnam Hospital Precision

  Coronary intervention being performed. Hallym University Kangnam Sacred Heart Hospital announced that it has become the first among hospitals under Hallym University Medical Center to introduce the latest artificial intelligence (AI)-based coronary blood flow analysis system, “μFR AngioPlus Core” (μ

  2026.02.11
• 
  Public Health

  Korea’s Pneumonia NIP Should Shift to Conjugate Vaccine

  Pneumonia has early symptoms such as cough and fever that are similar to those of a common cold, making early recognition and response difficult and making it hard for patients to perceive warning signs. In particular, among older adults, pneumonia can rapidly progress to a severe stage in a short p

  2026.02.11
• 
  Global Expansion

  K-Medicine Transforms Arthritis Care With Cartilage Regeneration

  Anselm Muegele (54, left), who came from Germany to Gangnam JS Hospital for articular cartilage restoration surgery and bowleg correction surgery, and Hospital Director Kim Na-min. Provided by Gangnam JS Hospital “As my knees improved, my life improved as well.”This is what patients who have undergo

  2026.02.11
• 
  Global Expansion

  Celltrion’s Remsima Tops KRW 1 Trillion Sales Again

  Celltrion’s autoimmune disease treatment “Remsima (ingredient name: infliximab)” has surpassed annual sales of KRW 1 trillion for the second consecutive year, firmly maintaining its position as Korea’s first global blockbuster pharmaceutical product. Industry assessments attribute this performance t

  2026.02.10
• 
  MedTech

  ‘Immune Shield’ Developed to Halt Organ Rejection

  ⓒNewsis The biggest challenge in organ transplantation, immune rejection, can now be suppressed without side effects thanks to a newly developed technology. Pohang University of Science and Technology (POSTECH) announced on the 9th that, together with a research team from Ewha Womans University, it

  2026.02.10
• 
  Biopharma

  Targeted Cancer Radiopharmaceuticals Intensify Global Crown Race

  The market for radiopharmaceuticals (RPT), which selectively eliminate only cancer cells, has been expanding rapidly in recent years. Because radioactive substances that are highly effective at destroying cancer cells can be targeted exclusively at those cells, these drugs have the advantage of fewe

  2026.02.10
• 
  MedTech

  POSTECH Develops Sprayable Immunosuppressant for Transplants

  AI-generated image The most significant challenge in organ transplantation, immune rejection, may be suppressed without side effects thanks to a newly developed technology. Pohang University of Science and Technology (POSTECH) announced on the 9th that, together with a research team from Ewha Womans

  2026.02.09
• 
  Bio & Pharma / Global Health

  Korea United Pharm Speeds UN Cancer Drug Supply

  Korea United Pharm Inc. announced on the 9th that it is substantially increasing its supply of anticancer drugs in the public procurement market targeting the UN and international organizations. This initiative is being pursued through cooperation with Denmark-based Missionpharma.Korea United Pharm

  2026.02.09